Interaction between human osteosarcoma and mesenchymal stem cells via an interleukin-8 signaling loop in the tumor microenvironment.
Interaction between human osteosarcoma and mesenchymal stem cells via an interleukin-8 signaling loop in the tumor microenvironment.
复制标题
DOI:
10.1186/s12964-018-0225-2
复制
发表时间:
2018-04-06
期刊:
影响因子:
--
通讯作者:
Tsumura H
中科院分区:
文献类型:
--
作者:
Kawano M;Tanaka K;Itonaga I;Iwasaki T;Tsumura H
Osteosarcoma (OS) is the representative primary malignant bone tumor with the highest incidence. It is known that malignant phenotypes of OS, such as proliferation, invasion, and metastasis, are significantly influenced not only by characteristics of the tumor itself, but also by the surrounding microenvironment. In other words, OS is considered to utilize cells in the vicinity of the tumor by changing the characteristics of these cells. Direct intercellular contact is believed to be important for this phenomenon. In the present study, we hypothesized that an interaction mediated by a humoral factor, requiring no cellular contact, might play a significant role in the progression of OS. We developed a new co-culture model, using OS cells and mesenchymal stem cells (MSCs) without cellular contact, and found that both cell types expressed IL-8 at a high level, and FAK in OS cells was phosphorylated leading to an increase in the metastatic potential of the tumor in the co-culture condition. It was revealed that OS cells formed a loop of signal cross-talk in which they released IL-8 as a paracrine factor, stimulating MSCs to express IL-8, and received IL-8 released by MSCs to accelerate IL-8 expression in OS cells. Administration of anti-IL-8 antibody resulted in the inhibition of FAK expression, its downstream signaling, and the invasive potential of the OS cells, resulting in decrease in metastatic lesions. The present study might lead not only to the clarification of a new molecular mechanism of invasion and metastasis of OS, but also to the development of a new therapeutic strategy of blocking IL-8 in OS.
登录
查看更多内容
影响因子:
11.2
作者:
Liu S;Ginestier C;Ou SJ;Clouthier SG;Patel SH;Monville F;Korkaya H;Heath A;Dutcher J;Kleer CG;Jung Y;Dontu G;Taichman R;Wicha MS
通讯作者:
Wicha MS
影响因子:
--
作者:
Han S;Xu W;Wang Z;Qi X;Wang Y;Ni Y;Shen H;Hu Q;Han W
通讯作者:
Han W
影响因子:
21.3
作者:
Kajiro, Masashi;Hirota, Ryuichi;Yanagisawa, Junn
通讯作者:
Yanagisawa, Junn
DOI:
10.1158/1541-7786.mcr-12-0275
发表时间:
2012-10
期刊:
Molecular cancer research : MCR
影响因子:
--
作者:
Bohrer LR;Schwertfeger KL
通讯作者:
Schwertfeger KL
影响因子:
8.8
作者:
Kitadai Y;Takahashi Y;Haruma K;Naka K;Sumii K;Yokozaki H;Yasui W;Mukaida N;Ohmoto Y;Kajiyama G;Fidler IJ;Tahara E
通讯作者:
Tahara E